Invitae Corp (NVTAQ)
0.0006
0.00 (0.00%)
USD |
OTCM |
May 13, 11:18
Invitae Enterprise Value: 1.097B for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 1.097B |
| May 09, 2024 | 1.098B |
| May 08, 2024 | 1.097B |
| May 07, 2024 | 1.097B |
| May 06, 2024 | 1.097B |
| May 03, 2024 | 1.097B |
| May 02, 2024 | 1.097B |
| May 01, 2024 | 1.097B |
| April 30, 2024 | 1.097B |
| April 29, 2024 | 1.097B |
| April 26, 2024 | 1.097B |
| April 25, 2024 | 1.099B |
| April 24, 2024 | 1.097B |
| April 23, 2024 | 1.097B |
| April 22, 2024 | 1.097B |
| April 19, 2024 | 1.097B |
| April 18, 2024 | 1.097B |
| April 17, 2024 | 1.097B |
| April 16, 2024 | 1.097B |
| April 15, 2024 | 1.097B |
| April 12, 2024 | 1.099B |
| April 11, 2024 | 1.096B |
| April 10, 2024 | 1.097B |
| April 09, 2024 | 1.097B |
| April 08, 2024 | 1.096B |
| Date | Value |
|---|---|
| April 05, 2024 | 1.096B |
| April 04, 2024 | 1.098B |
| April 03, 2024 | 1.100B |
| April 02, 2024 | 1.099B |
| April 01, 2024 | 1.099B |
| March 28, 2024 | 1.100B |
| March 27, 2024 | 1.100B |
| March 26, 2024 | 1.100B |
| March 25, 2024 | 1.100B |
| March 22, 2024 | 1.101B |
| March 21, 2024 | 1.101B |
| March 20, 2024 | 1.101B |
| March 19, 2024 | 1.101B |
| March 18, 2024 | 1.101B |
| March 15, 2024 | 1.101B |
| March 14, 2024 | 1.101B |
| March 13, 2024 | 1.101B |
| March 12, 2024 | 1.101B |
| March 11, 2024 | 1.101B |
| March 08, 2024 | 1.101B |
| March 07, 2024 | 1.101B |
| March 06, 2024 | 1.101B |
| March 05, 2024 | 1.101B |
| March 04, 2024 | 1.101B |
| March 01, 2024 | 1.102B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
654.39M
Minimum
Mar 18 2020
10.62B
Maximum
Jan 20 2021
3.124B
Average
1.742B
Median
Enterprise Value Benchmarks
| Laboratory Corp of America Holdings | 22.51B |
| Delcath Systems Inc | 122.95M |
| Star Equity Holdings Inc | 12.17M |
| CytoSorbents Corp | 40.30M |
| Progyny Inc | 2.286B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -942.11M |
| Revenue (Quarterly) | 121.24M |
| Total Expenses (Quarterly) | 224.14M |
| EPS Diluted (Quarterly) | -3.42 |
| Gross Profit Margin (Quarterly) | 32.21% |
| Profit Margin (Quarterly) | -777.1% |
| Earnings Yield | -896.7K% |
| Normalized Earnings Yield | -302330.7 |